Malignant Sinonasal Neoplasm

subtype

Identifier: CI-CAN-00001177
Entity page: /cancer/malignant-sinonasal-neoplasm ↗
Edges: 102

Neighbours: 32 drugs10 trials
Drawn: 42 of 42 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Malignant Sinonasal Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived32 of 32show fewer
→ investigated in trials for	Cisplatinsmall molecule 14 trials (10 active) · roll-up of the cancer and its descendants	—	—	Malignant Sinonasal Neoplasm	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall molecule

Malignant Sinonasal Neoplasm studied in …STUDIED_INderived10 of 70show all (up to 200)
→ studied in	NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 70 trials mapped (36 active)	—	—	Sinonasal Neuroendocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 70 trials mapped (36 active)	—	—	Nasal Cavity Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 70 trials mapped (36 active)	—	—	Malignant Sinonasal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ONTOLOGY_EXACT · 70 trials mapped (36 active)	—	—	Sinonasal Undifferentiated Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06176989Phase 2 · recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors · condition mapped CURATED_BROADER · 70 trials mapped (36 active)	—	—	Sinonasal Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03493425Phase 2 · active not recruiting Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery · condition mapped CURATED_BROADER · 70 trials mapped (36 active)	—	—	Sinonasal Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05546827Phase 2 · recruiting Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma · condition mapped ALIAS · 70 trials mapped (36 active)	—	—	Sinonasal Mucosal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07281417Phase 2 · recruiting Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 70 trials mapped (36 active)	—	—	Malignant Sinonasal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 70 trials mapped (36 active)	—	—	Malignant Sinonasal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06940180Phase 2 · recruiting Toripalimab With Chemotherapy for Sinus Cancer · condition mapped ALIAS · 70 trials mapped (36 active)	—	—	Malignant Sinonasal Neoplasm	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains